MGNX · Macrogenics Inc · Webcasts, Transcripts & Audio
$3.58
-0.02 (-0.56%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$238.24M
Shares
63.70M
Volume · Oct 2
980.53K
Avg daily vol (3M)
633.16K
Macrogenics Inc Webcasts
Earnings calls, investor updates, investor days and conferences for Macrogenics Inc (MGNX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▼14.2%
$15.66M
−$52.89M
'21 Q3
21-11-02
▼73.2%
$14.15M
−$58.02M
'21 Q4
22-02-24
▼34.2%
$11.10M
−$66.44M
'22 Q1
22-05-03
▼15.4%
$26.01M
−$41.30M
'22 Q2
22-08-08
▲166.5%
$41.73M
−$24.81M
'22 Q3
22-11-03
▲416.7%
$73.10M
$12.80M
'22 Q4
23-03-15
▲120.7%
$24.50M
−$38.01M
'23 Q1
23-05-09
▼49.5%
$13.14M
$57.47M
'23 Q2
23-08-09
▼75.1%
$10.40M
$17.55M
'23 Q3
23-11-06
▼85.3%
$10.72M
−$46.07M
'23 Q4
24-03-07
▼62.8%
$9.10M
−$52.19M
'24 Q1
24-05-09
▼17.8%
$10.80M
−$55.66M
'24 Q2
24-08-06
▲964.8%
$110.71M
$56.31M
'24 Q3
24-11-05
▲80.5%
$19.35M
−$15.42M
'24 Q4
25-03-20
▲44.9%
$13.19M
−$41.04M
'25 Q1
25-05-13
LATEST
▲57.5%
$20.77M
−$36.77M
'26 Q1
26-05-20
Earnings call
FY26 · Q1
2026-05-20
Macrogenics Inc (MGNX) Q1 2026 Earnings Call
Revenue
$20.77M
▲ 57.5% YoY Diluted EPS
$-0.58
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-13
Macrogenics Inc (MGNX) Q1 2025 Earnings Call
Revenue
$13.19M
▲ 44.9% YoY Diluted EPS
$-0.65
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-20
Macrogenics Inc (MGNX) Q4 2024 Earnings Call
Revenue
$19.35M*
▲ 80.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-05
Macrogenics Inc (MGNX) Q3 2024 Earnings Call
Revenue
$110.71M
▲ 964.8% YoY Diluted EPS
$0.90
▲ 221.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
Macrogenics Inc (MGNX) Q2 2024 Earnings Call Transcript
Positive tone
TAMARACK Phase II and vobra duo in mCRPC
B7-H3 pipeline strategy (MGC026, enoblituzumab)
R&D expense growth
Revenue
$10.80M
▼ 17.8% YoY Diluted EPS
$-0.89
▼ 196.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
Macrogenics Inc (MGNX) Q1 2024 Earnings Call Transcript
Positive tone
TAMARACK Phase II study (vobramitamab duocarmazine in mCRPC)
Dose selection between 2 mg/kg and 2.7 mg/kg
Durability / response confirmation
Revenue
$9.10M
▼ 62.8% YoY Diluted EPS
$-0.84
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-07
Macrogenics Inc (MGNX) Q4 2023 Earnings Call Transcript
Positive tone
Vobramitamab duocarmazine (vobra duo) / TAMARACK Phase 2
ADC pipeline expansion
Lorigerlimab / LORIKEET study
Revenue
$10.72M*
▼ 85.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-06
Macrogenics Inc (MGNX) Q3 2023 Earnings Call Transcript
Revenue
$10.40M
▼ 75.1% YoY Diluted EPS
$0.28
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
Macrogenics Inc (MGNX) Q2 2023 Earnings Call Transcript
Revenue
$13.14M
▼ 49.5% YoY Diluted EPS
$0.92
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Macrogenics Inc (MGNX) Q1 2023 Earnings Call Transcript
Revenue
$24.50M
▲ 120.7% YoY Diluted EPS
$-0.61
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-15
Macrogenics Inc (MGNX) Q4 2022 Earnings Call Transcript
Revenue
$73.10M*
▲ 416.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Macrogenics Inc (MGNX) Q3 2022 Earnings Call Transcript
Revenue
$41.73M
▲ 166.5% YoY Diluted EPS
$-0.40
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-08
Macrogenics Inc (MGNX) Q2 2022 Earnings Call Transcript
Revenue
$26.01M
▼ 15.4% YoY Diluted EPS
$-0.67
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-03
Macrogenics Inc (MGNX) Q1 2022 Earnings Call Transcript
Revenue
$11.10M
▼ 34.2% YoY Diluted EPS
$-1.08
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-24
Macrogenics Inc (MGNX) Q4 2021 Earnings Call Transcript
Revenue
$14.15M*
▼ 73.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-02
Macrogenics Inc (MGNX) Q3 2021 Earnings Call Transcript
Revenue
$15.66M
▼ 14.2% YoY Diluted EPS
$-0.86
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-29
Macrogenics Inc (MGNX) Q2 2021 Earnings Call Transcript
Revenue
$30.76M
▲ 51.8% YoY Diluted EPS
$-0.66
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-04-29
Macrogenics Inc (MGNX) Q1 2021 Earnings Call Transcript
Revenue
$16.88M
▲ 23.4% YoY Diluted EPS
$-0.90
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-25
Macrogenics Inc (MGNX) Q4 2020 Earnings Call Transcript
Revenue
$52.69M*
▲ 109.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-04
Macrogenics Inc (MGNX) Q3 2020 Earnings Call Transcript
Revenue
$18.25M
▼ 2.6% YoY Diluted EPS
$-0.66
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-31
Macrogenics Inc (MGNX) Q2 2020 Earnings Call Transcript
Revenue
$20.26M
▲ 91.2% YoY Diluted EPS
$-0.94
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-05
Macrogenics Inc (MGNX) Q1 2020 Earnings Call Transcript
Revenue
$13.68M
▲ 41.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–22 of 22 webcasts